These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 27160298)

  • 21. Electrocardiographic left ventricular hypertrophy and outcome in hemodialysis patients.
    Kim SJ; Oh HJ; Yoo DE; Shin DH; Lee MJ; Kim HR; Park JT; Han SH; Yoo TH; Choi KH; Kang SW
    PLoS One; 2012; 7(4):e35534. PubMed ID: 22530043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interrelations Between Hypertension and Electrocardiographic Left Ventricular Hypertrophy and Their Associations With Cardiovascular Mortality.
    Cao X; Broughton ST; Waits GS; Nguyen T; Li Y; Soliman EZ
    Am J Cardiol; 2019 Jan; 123(2):274-283. PubMed ID: 30390988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Electrocardiographic strain pattern in children with left ventricular hypertrophy: a marker of ventricular dysfunction.
    Shah N; Chintala K; Aggarwal S
    Pediatr Cardiol; 2010 Aug; 31(6):800-6. PubMed ID: 20422173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of a new electrocardiographic method for diagnosis of left ventricular hypertrophy in essential hypertension.
    Verdecchia P; Schillaci G; Borgioni C; Ciucci A; Gattobigio R; Zampi I; Porcellati C
    J Am Coll Cardiol; 1998 Feb; 31(2):383-90. PubMed ID: 9462583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Achieving a Systolic Blood Pressure Below 130 mmHg Reduces the Incidence of Cardiovascular Events in Hypertensive Patients with Echocardiographic Left Ventricular Hypertrophy.
    Lembo M; Trimarco V; Izzo R; Manzi MV; Rozza F; Gallo P; Morisco C; Bardi L; Esposito G; Forzano I; Santulli G; Trimarco B
    J Pharmacol Exp Ther; 2024 Jun; 390(1):4-10. PubMed ID: 38135511
    [No Abstract]   [Full Text] [Related]  

  • 26. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events.
    Okin PM; Devereux RB; Jern S; Kjeldsen SE; Julius S; Nieminen MS; Snapinn S; Harris KE; Aurup P; Edelman JM; Wedel H; Lindholm LH; Dahlöf B;
    JAMA; 2004 Nov; 292(19):2343-9. PubMed ID: 15547161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Additional impact of electrocardiographic over echocardiographic diagnosis of left ventricular hypertrophy for predicting the risk of ischemic stroke.
    Kohsaka S; Sciacca RR; Sugioka K; Sacco RL; Homma S; Di Tullio MR
    Am Heart J; 2005 Jan; 149(1):181-6. PubMed ID: 15660051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Left Ventricular Hypertrophy and Mortality Risk in Male Veteran Patients at High Cardiovascular Risk.
    Papademetriou V; Stavropoulos K; Kokkinos P; Doumas M; Imprialos K; Thomopoulos C; Faselis C; Tsioufis C
    Am J Cardiol; 2020 Mar; 125(6):887-893. PubMed ID: 31983390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subclassification of left ventricular hypertrophy based on dilation stratifies coronary artery disease patients with distinct risk.
    Huang BT; Peng Y; Liu W; Zhang C; Huang FY; Wang PJ; Zuo ZL; Liao YB; Chai H; Li Q; Zhao ZG; Luo XL; Ren X; Huang KS; Meng QT; Chen C; Huang DJ; Chen M
    Eur J Clin Invest; 2014 Oct; 44(10):893-901. PubMed ID: 25104141
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electrocardiographic criteria for the diagnosis of abnormal hypertensive cardiac phenotypes.
    Jiang X; Quan X; Yang J; Zhou X; Hu A; Zhang Y
    J Clin Hypertens (Greenwich); 2019 Mar; 21(3):372-378. PubMed ID: 30706989
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prognostic value of electrocardiographic estimation of left ventricular hypertrophy in dialysis patients.
    Covic AC; Buimistriuc LD; Green D; Stefan A; Badarau S; Kalra PA
    Ann Noninvasive Electrocardiol; 2013 Mar; 18(2):188-98. PubMed ID: 23530490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of heart failure hospitalizations with combined electrocardiography and echocardiography criteria for left ventricular hypertrophy.
    Gerdts E; Okin PM; Boman K; Wachtell K; Nieminen MS; Dahlöf B; Devereux RB
    Am J Hypertens; 2012 Jun; 25(6):678-83. PubMed ID: 22456225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic impact of baseline and serial changes in electrocardiographic left ventricular hypertrophy in resistant hypertension.
    Salles GF; Cardoso CR; Fiszman R; Muxfeldt ES
    Am Heart J; 2010 May; 159(5):833-40. PubMed ID: 20435193
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interrelation Between Electrocardiographic Left Atrial Abnormality, Left Ventricular Hypertrophy, and Mortality in Participants With Hypertension.
    Ahmad MI; Mujtaba M; Anees MA; Li Y; Soliman EZ
    Am J Cardiol; 2019 Sep; 124(6):886-891. PubMed ID: 31324356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inter-relationship between electrocardiographic left ventricular hypertrophy and QT prolongation as predictors of increased risk of mortality in the general population.
    Soliman EZ; Shah AJ; Boerkircher A; Li Y; Rautaharju PM
    Circ Arrhythm Electrophysiol; 2014 Jun; 7(3):400-6. PubMed ID: 24762807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Accuracy and prognostic significance of electrocardiographic markers of left ventricular hypertrophy in a general population: findings from the Pressioni Arteriose Monitorate E Loro Associazioni population.
    Cuspidi C; Facchetti R; Bombelli M; Sala C; Grassi G; Mancia G
    J Hypertens; 2014 Apr; 32(4):921-8. PubMed ID: 24406778
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Consistency of left ventricular hypertrophy diagnosed by electrocardiography and echocardiography: the Northern Shanghai Study.
    Zhang W; Zhou Y; Bai B; Yu S; Xiong J; Chi C; Teliewubai J; Li J; Blacher J; Zhang Y; Xu Y
    Clin Interv Aging; 2019; 14():549-556. PubMed ID: 30880935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Electrocardiographic left ventricular hypertrophy and the risk of adverse cardiovascular events: a critical appraisal.
    Rautaharju PM; Soliman EZ
    J Electrocardiol; 2014; 47(5):649-54. PubMed ID: 25012077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Four ECG left ventricular hypertrophy criteria and the risk of cardiovascular events and mortality in patients with vascular disease.
    van Kleef MEAM; Visseren FLJ; Vernooij JWP; Nathoe HM; Cramer MM; Bemelmans RHH; van der Graaf Y; Spiering W;
    J Hypertens; 2018 Sep; 36(9):1865-1873. PubMed ID: 29878973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Electrocardiographic left ventricular hypertrophy and mortality in an oldest-old hypertensive Chinese population.
    Chen R; Bai K; Lu F; Zhao Y; Pan Y; Wang F; Zhang L
    Clin Interv Aging; 2019; 14():1657-1662. PubMed ID: 31571845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.